These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Pappert EJ; Germanson T; Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274 [TBL] [Abstract][Full Text] [Related]
4. Quality of sleep in primary focal dystonia: a case-control study. Avanzino L; Martino D; Marchese R; Aniello MS; Minafra B; Superbo M; Defazio G; Abbruzzese G Eur J Neurol; 2010 Apr; 17(4):576-81. PubMed ID: 20039936 [TBL] [Abstract][Full Text] [Related]
5. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193 [TBL] [Abstract][Full Text] [Related]
6. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W; J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667 [TBL] [Abstract][Full Text] [Related]
7. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697 [TBL] [Abstract][Full Text] [Related]
8. Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia. Costanzo M; Belvisi D; Berardelli I; Maraone A; Baione V; Ferrazzano G; Cutrona C; Leodori G; Pasquini M; Conte A; Fabbrini G; Defazio G; Berardelli A Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564651 [TBL] [Abstract][Full Text] [Related]
9. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study. Moll M; Rosenthal D; Hefter H Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Factor SA; Molho ES; Evans S; Feustel PJ Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134 [TBL] [Abstract][Full Text] [Related]
11. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study. Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454 [TBL] [Abstract][Full Text] [Related]
15. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment. Camargo CH; Cattai L; Teive HA Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508 [TBL] [Abstract][Full Text] [Related]
16. Dynamic cortical gray matter volume changes after botulinum toxin in cervical dystonia. Delnooz CC; Pasman JW; van de Warrenburg BP Neurobiol Dis; 2015 Jan; 73():327-33. PubMed ID: 25447226 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A and cervical dystonia: a seven-year follow-up. Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174 [TBL] [Abstract][Full Text] [Related]
18. Impaired heart rate variability in cervical dystonia is associated to depression. Hentschel F; Dressler D; Abele M; Paus S J Neural Transm (Vienna); 2017 Feb; 124(2):245-251. PubMed ID: 27816992 [TBL] [Abstract][Full Text] [Related]
19. RimabotulinumtoxinB effects on pain associated with cervical dystonia: results of placebo and comparator-controlled studies. Lew MF; Chinnapongse R; Zhang Y; Corliss M Int J Neurosci; 2010 Apr; 120(4):298-300. PubMed ID: 20374078 [TBL] [Abstract][Full Text] [Related]
20. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A. Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]